Read the Registration Document - Guerbet

More documents

Recommendations

Info

In 2005, the Group acquired for ¥593 million on a present value basis from the previous distributor ofImagenil (Oxilan) in Japan various intangible assets destined to maintain the commercial relations existingwith the Japanese customer base when the distribution was transferred to Terumo. At 31 December 2010,the net carrying value after amortisation had been fully written down. These intangible assets were writtenoff in 2012.Business goodwill was acquired from former Group distributors when commercial subsidiaries were openedin various countries. This goodwill was amortised over 20 years until the IFRS transition date of 31December 2003. Because the useful life of this goodwill is currently considered indefinite, as of 1 January2004 it was no longer amortised.Software is amortised over its useful life that is generally approximately three years.Estimates of recoverable values of cash generating units including goodwill or indefinite life intangibleassets representing material amounts:The cash generating units were as follows:Cash generating units Goodwill and intangible assets Net carrying valueTrademarks (Magnescope) 1,325JapanCommercial relations -Marketing authorisations 6,114Patents 1,745GermanyTrademarks (Barium) 7,476Goodwill 990South Korea Goodwill 4,252Italy Goodwill 3,796Medex Patent 2,079At 31 December 2012, impairment tests were conducted on the basis of discounted cash flows determinedaccording to the medium-term plan or more detailed data. This MTP covers the years from 2013 to 2017.A discount rate of 4.85% was applied to all assets other than of Japan (3.70%).The calculation of value in use does not incorporate the notion of a terminal value. For each of these CGUs,the present value of future cash flows exceeds the net carrying value. In respect to sensitivity, a 1 pointvariance in interest rates would not have resulted in the recognition of an impairment charge.93
Note 6 – Property, plant and equipment6.1 – Analysis of changes by type of asset31/12/2011 Increase DecreaseOtherchangesCurrencytranslationadjustments31/12/2012Land 6,254 (28) 6,226- including capital leases 2 2Buildings 97,525 6,990 (2,561) (660) 101,294- including capital leases 2,501 2,501Machinery and equipment 161,227 8,504 (5,591) (606) 163,534- including capital leases 7,996 7,996Other tangible assets 47,981 5,929 (4,907) (538) 48,465- including capital leases 3,814 1,729 (891) 4,652Construction in progress 51,027 8,213 (1,457) (126) 57,657Advances and instalments onfixed assets546 13 559Cost 364,560 29,649 (14,516) (1,958) 377,735Allowances for depreciation (181,419) (20,069) 12,265 1,070 (188,153)Impairment - -Net 183,141 9,580 (2,251) (888) 189,58231/12/2010 Increase DecreaseOtherchangesCurrencytranslationadjustments31/12/2011Land 6,271 (17) 6,254- including capital leases 2 2Buildings 97,567 4,409 (3,959) 44 (536) 97,525- including capital leases 2,501 2,501Machinery and equipment 159,507 9,655 (9,028) 1,511 (418) 161,227- including capital leases 7,408 588 7,996Other tangible assets 46,354 6,426 (4,381) 18 (436) 47,981- including capital leases 3,264 550 3,814Construction in progress 33,159 19,558 (1) (1,587) (102) 51,027Advances and instalments onfixed assets3,216 (2,670) 546Cost 346,074 37,378 (17,369) (14) (1,509) 364,560Allowances for depreciation (179,851) (18,965) 16,550 22 825 (181,419)Impairment - -Net 166,223 18,413 (819) 8 (684) 183,141Significant capital expenditures in 2012 have included notably:- Production capacity investments for the Lanester, Marans and Aulnay sites (including €9 million for anew primary packaging facility);- Investments to improve safety and backfit all French plants.94
Page 3 and 4:
CONTENTSCHIEF EXECUTIVE OFFICERS’
Page 5 and 6:
CHIEF EXECUTIVE OFFICERS’ MESSAGE
Page 7 and 8:
THE GUERBET GROUP1) History of the
Page 9 and 10:
3) Business overview3.1 Guerbet is
Page 11 and 12:
3.4 The pathologiesIn Oncology, the
Page 13:
Guerbet's offering of products is c
Page 16 and 17:
c) Research & development• R&D ob
Page 18 and 19:
• A proactive partnering strategy
Page 20 and 21:
5) Group organisation at 31 Decembe
Page 22 and 23:
e) DistributionGuerbet distribute i
Page 24 and 25:
DirectorsOther offices and director
Page 26 and 27:
There exist no arrangements or unde
Page 28 and 29:
Summary of compensation for Marie-C
Page 30 and 31:
• Stock options granted to non-of
Page 32 and 33:
I - 1Organisation of the work of th
Page 34 and 35:
"Research and Innovation" Committee
Page 36 and 37:
II - Internal control and risk mana
Page 38 and 39:
4) Statutory Auditors’ report pre
Page 40 and 41:
SHAREHOLDER INFORMATION1) The Guerb
Page 42 and 43:
As at 31 December 2010SHARESVOTING
Page 44 and 45: considered to have automatically re
Page 46 and 47: 10) Provisions of the Articles of A
Page 48 and 49: c) Earnings highlightsIFRS(in thous
Page 50 and 51: g) OutlookStrongly focused on the n
Page 52 and 53: 3) Risk factorsThe company conducte
Page 54 and 55: • Sourcing risksGuerbet has an ex
Page 56 and 57: • Information technology risksAn
Page 58 and 59: • Five-year summary of consolidat
Page 60 and 61: • Other information included in t
Page 62 and 63: • Recruitment and dismissalsGuerb
Page 64 and 65: and employee savings. The goal is s
Page 66 and 67: • Measures adopted to promote emp
Page 68 and 69: ) Pollution and waste managementThe
Page 70 and 71: 3) Societal informationa) Territori
Page 72 and 73: • Consolidated income statementIn
Page 74 and 75: In thousands of euros• Statement
Page 76 and 77: Changes in standards and interpreta
Page 78 and 79: g) Research and development expendi
Page 80 and 81: Held to maturity investmentsHeld-to
Page 82 and 83: creation are recorded under "Other
Page 84 and 85: III) Notes to the financial stateme
Page 86 and 87: Aged trial balance information for
Page 88 and 89: 2.2 - Borrowings by currencyCurrenc
Page 90 and 91: 3.3 - Analysis of the sensitivity o
Page 92 and 93: Revenue2012European companiesfor th
Page 96 and 97: 6.2 - Analysis of property, plant a
Page 98 and 99: The change in the net value of inve
Page 100 and 101: 12.2 - Accrued employee benefitsa)
Page 102 and 103: Change in net liabilities of the pe
Page 104 and 105: 14.4 - Personnel by region at year-
Page 106 and 107: Note 22 - Research and development
Page 108 and 109: Note 25 - Related parties25.1 - Rel
Page 110 and 111: Note 27 - Basic earnings per share
Page 112 and 113: 2) Auditors’ report on the consol
Page 114 and 115: 3) Parent company financial stateme
Page 116 and 117: • Income statementIn thousands of
Page 118 and 119: • Statement of cash flowsIn milli
Page 120 and 121: c) Property, plant and equipmentPro
Page 122 and 123: Note 1 - Intangible assets1 - 1 - C
Page 124 and 125: Note 6 - Receivables by maturityCos
Page 126 and 127: Note 9 - Regulated provisionsInvest
Page 128 and 129: Note 13 - Sales by region2012 2011F
Page 130 and 131: Tax income or expense recorded in t
Page 132 and 133: Debt waiver agreements granted to a
Page 134 and 135: Capital lease commitments relative
Page 136 and 137: 4) Auditors' report on the separate
Page 138 and 139: 5) Auditors' special report on rela
Page 140 and 141: ORDINARY AND EXTRAORDINARY GENERAL
Page 142 and 143: RESOLUTION THREE (Special report of
Page 144 and 145:
Extraordinary resolutionsRESOLUTION
Page 146 and 147:
3) Report of the Board of Directors
Page 148 and 149:
Application of legal provisions gov
Page 150 and 151:
• Tenth draft resolution: stock s
Page 152 and 153:
2) The Statutory Auditorsa) Statuto
Page 154 and 155:
6) Articles of association (selecte
Page 156 and 157:
7) 2013 shareholders calendarEventD
Page 158 and 159:
) Annual financial reportInformatio
show all

Read the Registration Document - Guerbet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?